Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Colon Surgery
Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Colon Surgery
EPIFLO® unit along with standard wound care vs only standard wound care for Surgical site
 infections (SSI).
Anorectal procedures more often lead to surgical site infections. Such infections are
 unfortunately frequent and can be difficult for the patient and the treating physician. Wound
 hypoxia has been identified as a pathogenic mechanism behind wound infection and poor
 healing. Transdermal oxygen delivery (EPIFLO) is intended to promote the healing process in
 chronic wounds as an adjunct to standard wound care in wound management and treatment
Inclusion Criteria:

 -  Elective colo-rectal surgery with or without anastomosis and with or without stoma

 -  Patient age: 18-80

 Exclusion Criteria:

 -  Pregnancy

 -  Anesthesiology ASA score of 4 or above

 -  fever or existing signs of infection at the time of surgery

 -  Diabetes Mellitus type I or II with HbA1C level 12% or more

 -  Persons with decubitus or diabetic ulcers

 -  Subjects with peritoneal metastases

 -  Patients with severe malnutrition as indicated by Prealbumin value of <20

 -  BMI ≥50